Prefer a chat interface with context about you and your work?
Using short-term endpoints to improve interim decision making and trial duration in two-stage phase II trials with nested binary endpoints
In oncology, phase II clinical trials are often planned as single-arm two-stage designs with a binary endpoint, for example, progression-free survival after 12 months, and the option to stop for futility after the first stage. Simon’s two-stage design is a very popular approach but depending on the follow-up time required …